Member Info for Laura2022

Almost one every few weeks now

award of a second contract by a UK-based biotech client at the forefront of AI-driven drug development. This follows the successful completion of a previous project with the same client, which was announced in June 2024 and fell into the Company's Modelling and Simulation division.

Under the new contract, Physiomics will update a model previously developed for the client, incorporating clinical data from their ongoing Phase 1 study. The updated model will be used to support critical decisions

As I said In my IR email reply last week they said updates soon on their assets and warrants

There's part 1

Project Overview

As previously announced, NovaCore holds approximately 15,000 acres in the Red Basin Uranium District of New Mexico, where historical U.S. Department of Energy assessments and recent radiometric surveys suggest there is potential for 40 million pounds of U₃O₈. Recently, NovaCore's gamma spectrometry surveys have identified multiple uranium-rich zones. The area has road access, a known permitting regime, and favourable geology with structural and geophysical targets that remain largely undrilled below 400 feet.

NovaCore has completed land staking, radiometric and geophysical surveys, and is advancing permitting and environmental studies to support forthcoming drilling.

NovaCore's board of directors includes Neil Herbert (Founder and Chairman) and Douglas Christopherson (Founder and Technical Advisor) both of whom played key roles in the management of AIM and TSX listed Uramin Inc. which was sold for US$2.5 billion.

Further information on the drill programme will be announced in due course.

12 posts PYC

5 posts FAB

Issues

As per this, you feel the need to instigate every barbed discussion , you have issues, just filter me ..but you won't or can't xx

Laura2022

Posts: 12,261

Price: 0.435

No Opinion

RE: Added1 Aug 2025 10:11

You maybe need to think about why you instigate evey disagreement and why your stories just never add up here and FAB and PYC

Enjoy the cricket ...I will also be

Here he is

Asks questions but doesnt answer

The one at 3.22pm took the ask from 0.45p to 0.5p

Is that OK now , can you sleep better

From c4pm

Expect more

He had posted x 3 more here at MET1 (almost 500 posts) than his entire other shares

Clintek

He cant , the last official 30mln were last week and admitted yesterday BUT already forward sold (including 19mln in one trade about a week ago

Hence why there were no after hours trades anywhere near 30mln late Monday..in fact tje 4 that were were from Friday

Clintek

All will fill most of these criteria

Pathetic people

Ive filtered 20+, some mainly in June as the sp went 8p to 27p

Many post 90-100% on MET1

Many have had LSE accounts for 10yrs but only started posting recently

Many /most were abusive

Many had huge gaps in their LSE history

Many work in unison, asking questions where the answers can be found in company document s

0.54p

Cellular

It regularly goes into mimin auction

Just try in a minute

5.2p paid

Eg MJandWandco

Not seen since 30th July, now on HAMA doing same routine

Filtered him weeks ago

100s off posts

Said for a week or so that MET1 may not repeat 8p to 27p from June but could well do 10p+

One buy took out the 0.45 ask

Massive proportion of cash warrants Done , ALL pre paid warrants done ( see RNS)

charts massively oversold

Huge uranium and critical minerals assets in safe jurisdictions

Cash and cash from warrants probably has MET1 at £8mln cash now V £19mln cap

Tomhh

You've changed your tune

3Cureent cap is £20mln

Net assets as of Dec 2024 0f c£8.6mln

Cash after placing £3mln+ £0.85mln from before

Plus will be £5-10mln from warrants by next accounts

Undervalued

at 31 December 2024, Metals One had net assets of £8,663,131 including cash and cash equivalents of £33,640. The cash position was bolstered in April 2025 following a retail offer and equity fundraise delivering net proceeds of £3.1 million. In April 2025, the Company issued cash warrants to the investors in the equity fundraise which are exercisable for a period of six months from the date of grant and, if exercised, would bring in up to £10 million in additional gross proceeds to the Company.